Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Australian seagulls found to carry antibiotic resistant bacteria
Silver gulls carry bacteria that are resistant to the commonly used antimicrobial drugs, cephalosporins and fluoroquinolones.
Birds earmarked as potential reservoirs for human disease

Seagulls across Australia carry antibiotic resistant bacteria that cause serious infections in humans, according to new research.

Scientists at Murdoch University, Perth, found that 20 per cent of silver gulls carry bacteria that cause infections such as E.coli, urinary tract infections and sepsis. Study leader Dr Sam Abraham said the problem was prevalent across Australia.

“Seagulls act as ecological sponges (bio-accumulators) and we have earmarked them as a potential reservoir for agents that may cause human disease,” he explained.

The study revealed that silver gulls carry bacteria that are resistant to the commonly used antimicrobial drugs, cephalosporins and fluoroquinolones. It also found resistance to carbapanem drugs - a class of antibiotics often used for severe infections - in birds from New South Wales and Victoria.

The researchers also found evidence of a seagull in Western Australia carrying resistance to the ‘last resort’ antibiotic, colistin. Study author Dr Mark O’Dea said it was the first time resistance to this drug has been recorded in an Australian wild animal.

“Our results have raised the concern that seagulls could be acquiring this pathogen through their opportunistic feeding habits where they scavenge from leftover human waste and may then be subsequently spreading these resistant bacteria over vast distances,” he said.

“Management of this issue will require examination of human waste sources to determine where gulls are acquiring these elements, and whether or not this can be managed.”

The study, Resistance to critically important antimicrobials in Australian silver gulls (Chroicocephalus novaehollandiae) and evidence of anthropogenic origins, is published in Antimicrobial Chemotherapy.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.